• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种评估人类前列腺癌转移潜能的新方法:相对核圆度

A new method to assess metastatic potential of human prostate cancer: relative nuclear roundness.

作者信息

Diamond D A, Berry S J, Jewett H J, Eggleston J C, Coffey D S

出版信息

J Urol. 1982 Oct;128(4):729-34. doi: 10.1016/s0022-5347(17)53158-4.

DOI:10.1016/s0022-5347(17)53158-4
PMID:7143594
Abstract

A new technique has been developed that helped in an accurate prediction of the prognosis of 27 patients with stages B1 and B2 prostatic cancer following radical prostatectomy. This method involves computer-assisted image analysis of histological specimens of the primary lesion removed at the time of radical perineal prostatectomy. On the basis of a nuclear shape factor, known as nuclear roundness, we have been able to distinguish those tumors with a high metastatic potential from tumors that are less aggressive. This technique provides pathologists with quantitative information about the metastatic potential of a tumor, which may aid in the management of the individual patient.

摘要

一种新技术已经被开发出来,它有助于准确预测27例B1期和B2期前列腺癌患者根治性前列腺切除术后的预后。该方法涉及对经会阴根治性前列腺切除术时切除的原发性病变组织学标本进行计算机辅助图像分析。基于一种称为核圆度的核形状因子,我们已经能够区分出具有高转移潜能的肿瘤和侵袭性较小的肿瘤。这项技术为病理学家提供了关于肿瘤转移潜能的定量信息,这可能有助于对个体患者的管理。

相似文献

1
A new method to assess metastatic potential of human prostate cancer: relative nuclear roundness.一种评估人类前列腺癌转移潜能的新方法:相对核圆度
J Urol. 1982 Oct;128(4):729-34. doi: 10.1016/s0022-5347(17)53158-4.
2
Nuclear shape analysis for the assessment of local invasion and metastases in clinically localized prostate carcinoma.用于评估临床局限性前列腺癌局部侵犯和转移的核形态分析。
Cancer. 1994 Dec 1;74(11):2996-3001. doi: 10.1002/1097-0142(19941201)74:11<2996::aid-cncr2820741117>3.0.co;2-9.
3
Nuclear roundness factor. A predictor of progression in untreated Stage A2 prostate cancer.核圆度因子。未经治疗的A2期前列腺癌进展的预测指标。
Cancer. 1984 Oct 15;54(8):1666-71. doi: 10.1002/1097-0142(19841015)54:8<1666::aid-cncr2820540830>3.0.co;2-7.
4
Nuclear morphometry in automatic biopsy and radical prostatectomy specimens of prostatic carcinoma. A comparison.前列腺癌自动活检和根治性前列腺切除术标本中的细胞核形态测量:一项比较研究。
Anal Quant Cytol Histol. 1994 Dec;16(6):415-20.
5
Chromatin changes predict recurrence after radical prostatectomy.染色质变化可预测前列腺癌根治术后的复发情况。
Br J Cancer. 2016 May 24;114(11):1243-50. doi: 10.1038/bjc.2016.96. Epub 2016 Apr 28.
6
Computerized image analysis of nuclear shape as a prognostic factor for prostatic cancer.作为前列腺癌预后因素的细胞核形态的计算机图像分析
Prostate. 1982;3(4):321-32. doi: 10.1002/pros.2990030402.
7
Quantitative alterations in nuclear structure predict prostate carcinoma distant metastasis and death in men with biochemical recurrence after radical prostatectomy.核结构的定量改变可预测根治性前列腺切除术后生化复发男性的前列腺癌远处转移和死亡情况。
Cancer. 2003 Dec 15;98(12):2583-91. doi: 10.1002/cncr.11852.
8
Nuclear roundness factor measurement for assessment of prognosis of patients with prostatic carcinoma. II. Standardization of methodology for histologic sections.用于评估前列腺癌患者预后的核圆度因子测量。II. 组织学切片方法的标准化
J Urol. 1988 May;139(5):1085-90. doi: 10.1016/s0022-5347(17)42792-3.
9
Nuclear deoxyribonucleic acid ploidy and serum prostate specific antigen in operable prostatic adenocarcinoma.
J Urol. 1990 Aug;144(2 Pt 1):303-6. doi: 10.1016/s0022-5347(17)39437-5.
10
[Management of prostate cancer in Senegal: what is being done?].[塞内加尔前列腺癌的管理:正在采取哪些措施?]
Prog Urol. 2013 Jan;23(1):36-41. doi: 10.1016/j.purol.2012.09.002. Epub 2012 Oct 15.

引用本文的文献

1
Nondestructive 3D pathology with analysis of nuclear features for prostate cancer risk assessment.用于前列腺癌风险评估的具有核特征分析的无损 3D 病理学。
J Pathol. 2023 Aug;260(4):390-401. doi: 10.1002/path.6090. Epub 2023 May 26.
2
Chromosome compartmentalization alterations in prostate cancer cell lines model disease progression.前列腺癌细胞系中染色体区室化改变模型疾病进展。
J Cell Biol. 2022 Feb 7;221(2). doi: 10.1083/jcb.202104108. Epub 2021 Dec 10.
3
Prognostic prostate tissue biomarkers of potential clinical use.有潜在临床应用价值的前列腺组织预后生物标志物。
Virchows Arch. 2014 Mar;464(3):293-300. doi: 10.1007/s00428-014-1540-7. Epub 2014 Feb 1.
4
Quantitative pathology: historical background, clinical research and application of nuclear morphometry and DNA image cytometry.定量病理学:核形态计量学和DNA图像细胞术的历史背景、临床研究与应用
Libyan J Med. 2006 Sep 20;1(2):126-39. doi: 10.4176/060911.
5
Large and round tumor nuclei in osteosarcoma: good clinical outcome.骨肉瘤中肿瘤细胞核大且圆:临床预后良好。
Int J Clin Exp Pathol. 2011 Jan 30;4(2):169-74.
6
Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivo.丙戊酸在体外和体内均会引起前列腺癌细胞的核结构发生剂量和时间依赖性变化。
Mol Cancer Ther. 2009 Apr;8(4):802-8. doi: 10.1158/1535-7163.MCT-08-1076.
7
DNA Ploidy as surrogate for biopsy gleason score for preoperative organ versus nonorgan-confined prostate cancer prediction.DNA倍体作为活检Gleason评分的替代指标用于术前预测前列腺癌是否局限于器官或超出器官范围。
Urology. 2009 May;73(5):1092-7. doi: 10.1016/j.urology.2008.09.060. Epub 2009 Feb 3.
8
Prognostic factors in prostate cancer.前列腺癌的预后因素。
Diagn Pathol. 2006 Apr 3;1:4. doi: 10.1186/1746-1596-1-4.
9
Prognostic value of nuclear morphometry in patients with TNM stage T1 ovarian clear cell adenocarcinoma.TNM分期为T1期的卵巢透明细胞腺癌患者中细胞核形态测量的预后价值。
Br J Cancer. 1999 Apr;79(11-12):1736-41. doi: 10.1038/sj.bjc.6690276.
10
Nuclear protein as a prognostic factor of growth activity in prostatic adenocarcinoma.核蛋白作为前列腺腺癌生长活性的预后因素。
Urol Res. 1996;24(5):251-5. doi: 10.1007/BF00304773.